Finally, the existence of a “paradoxical” subgroup of CRC (34% of CRCs) was identified that does not display an IFNγ response despite the secretion of mature IL-18 by tumor cells and that features downregulated IL-17, chemokines, and antimicrobial agent gene signatures. The gene discussed is IL18; the disease is neoplasm.